Home / Colecalciferol / Italy
IT ATC A11CC05 · updated 2 Nov 2026
Colecalciferol shortage in Italy
Is there a Colecalciferol shortage in Italy?
Yes. As of 2 Nov 2026, 10 Colecalciferol products are reported short in Italy, the first since 17 Oct 2022. The company estimate for the return is 31 Dec 2026 (latest 18 Apr 2027). Main reason: manufacturing problem.
Also short in Germany, Spain, Austria, Belgium, Switzerland, Norway, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | COLECALCIFEROLO ZENTIVA | ZENTIVA ITALIA S.R.L. | 17 Oct 2022 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | IBITRED | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.P.A. | 15 Oct 2024 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | IBITRED | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.P.A. | 15 Oct 2024 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | COLECALCIFEROLO ZENTIVA ITALIA | ZENTIVA ITALIA S.R.L. | 30 Nov 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | COLECALCIFEROLO MYLAN ITALIA | MYLAN S.P.A. | 10 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | COLECALCIFEROLO ZENTIVA ITALIA | ZENTIVA ITALIA S.R.L. | 9 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | COLECALCIFEROLO EG STADA ITALIA | PHARMACARE S.R.L. | 2 Sep 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | COLECALCIFEROLO TEVA B.V. | TEVA B.V. | 21 Sep 2026 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | DICOLEV anticipated | FIDIA SPECIALTY S.R.L. | 16 Nov 2026 | 18 Apr 2027 | Commercial decision or withdrawal Motivi commerciali |
| IT | COLECALCIFEROLO ZENTIVA ITALIA anticipated | ZENTIVA ITALIA S.R.L. | 30 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.